These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12427361)

  • 1. Update on the treatment of Kawasaki disease in childhood.
    Sundel RP
    Curr Rheumatol Rep; 2002 Dec; 4(6):474-82. PubMed ID: 12427361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
    Son MB; Gauvreau K; Burns JC; Corinaldesi E; Tremoulet AH; Watson VE; Baker A; Fulton DR; Sundel RP; Newburger JW
    J Pediatr; 2011 Apr; 158(4):644-649.e1. PubMed ID: 21129756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acute and refractory Kawasaki disease.
    Tacke CE; Burgner D; Kuipers IM; Kuijpers TW
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1203-15. PubMed ID: 23199405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile Kawasaki disease and peripheral gangrene.
    Durall AL; Phillips JR; Weisse ME; Mullett CJ
    J Pediatr; 2006 Jul; 149(1):131-3. PubMed ID: 16860142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH; Liu PM; Bong CN; Wu YT; Yang KD; Wang CL
    J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
    O'connor MJ; Saulsbury FT
    Clin Pediatr (Phila); 2007 May; 46(4):345-8. PubMed ID: 17475994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
    Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
    Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of Kawasaki disease.
    Dominguez SR; Anderson MS
    Curr Opin Pediatr; 2013 Feb; 25(1):103-9. PubMed ID: 23283289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
    Wallace CA; French JW; Kahn SJ; Sherry DD
    Pediatrics; 2000 Jun; 105(6):E78. PubMed ID: 10835091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of refractory kawasaki disease.
    Ng SH; Roshan S
    Med J Malaysia; 2018 Dec; 73(6):410-412. PubMed ID: 30647216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?
    McCandless RT; Minich LL; Tani LY; Williams RV
    Am J Cardiol; 2010 Jun; 105(11):1625-8. PubMed ID: 20494673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
    Raman V; Kim J; Sharkey A; Chatila T
    Pediatr Infect Dis J; 2001 Jun; 20(6):635-7. PubMed ID: 11419513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease.
    Stenbøg EV; Windelborg B; Hørlyck A; Herlin T
    Scand J Rheumatol; 2006; 35(4):318-21. PubMed ID: 16882598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.